Artificial intelligence–powered insulin dosing and virtual coaching offer faster answers and convenience, but accuracy and oversight are key to buildi...

Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and d...

Topline results, to be presented at an upcoming congress, show enfortumab vedotin and pembrolizumab significantly improve survival for muscle-invasive...

Interclass biologic switching can improve outcomes, but it also increases infection rates.

New long-term data highlights the effectiveness and safety of ivosidenib plus azacitidine for treating IDH1-mutated acute myeloid leukemia in vulnerab...

Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthr...

Sedentary behaviors are associated with increased CVD risk and, when combined with social drivers of health, increase the risk of adverse CVD events l...

Chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies are transforming multiple myeloma care, with earlier use, expanded community...

Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but inc...

Panelists discuss how upcoming ASCO presentations will focus on long-term CAR T-cell therapy outcomes showing potential cure plateaus, minimal residua...